No headlines found.
No press releases found.
No news found.
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.
Grifols S.A. - American Depositary Shares trades on the NASDAQ stock market under the symbol GRFS.
As of January 14, 2026, GRFS stock price climbed to $9.24 with 1,005,869 million shares trading.
GRFS has a beta of 0.74, meaning it tends to be less sensitive to market movements. GRFS has a correlation of 0.17 to the broad based SPY ETF.
GRFS has a market cap of $6.29 billion. This is considered a Mid Cap stock.
In the last 3 years, GRFS traded as high as $12.15 and as low as $5.30.
The top ETF exchange traded funds that GRFS belongs to (by Net Assets): IBB, BINV, KOMP, SPDW, BSMC.
GRFS has outperformed the market in the last year with a return of +30.2%, while the SPY ETF gained +20.0%. However, in the most recent history, GRFS shares have underperformed the stock market with its stock returning -2.2% in the last 3 month period and +0.4% for the last 2 week period, while SPY has returned +4.4% and +0.5%, respectively.
GRFS support price is $8.67 and resistance is $9.01 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GRFS shares will trade within this expected range on the day.
